BMY

Bristol Myers Squibb News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.62 2.6% 63.8601 19:11:04
Open Price Low Price High Price Close Price Prev Close
62.51 62.35 64.52 63.86 62.24
more quote information »

Recent News

Date Time Source Heading
1/26/202213:37TRMNBristol Myers: How Much Upside Is Left?
1/21/202217:41EDGARAnnual Statement of Changes in Beneficial Ownership (5)
1/12/202210:09TRMNBristol-Myers Squibb: Can Pipeline Offset Patent Expiry
1/10/202216:05PRNUSBioAtla Announces Clinical Collaboration with Bristol Myers..
1/10/202208:21DJNCentury Therapeutics Shares Rise 12% Premarket After Bristol..
1/10/202208:13SEEKBristol-Myers sets in-line guidance for 2022; announces $5B..
1/10/202207:47SEEKCentury jumps 14% on collaboration with Bristol Myers to..
1/10/202207:00EDGARCurrent Report Filing (8-k)
1/10/202206:59BWCentury Therapeutics and Bristol Myers Squibb Enter into a..
1/10/202206:45BWBristol Myers Squibb to Highlight Long-Term Growth Strategy..
1/04/202218:23EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202218:23EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202218:22EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202218:22EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202218:21EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202218:20EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202218:20EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202206:59BWBristol Myers Squibb to Present at J.P. Morgan’s 40th Annual..
12/30/202111:35TRMNBristol Myers (BMY) Receives a Buy from William Blair
12/20/202109:28DJNCorrection to FDA OKs Bristol Myers' Orencia Story
12/17/202117:09EDGARStatement of Changes in Beneficial Ownership (4)
12/17/202106:59BWBristol Myers Squibb to Report Results for Fourth Quarter..
12/15/202115:13BWU.S. Food and Drug Administration Approves Orencia®..
12/15/202112:44DJNFDA OKs Bristol Myers' Orencia in Acute Graft-Vs-Host..
12/15/202112:15SEEKBristol-Myers Squibb wins FDA approval for first graft..
12/15/202108:00TRMNBristol Myers Inks Licensing Agreement for IMA401 with..
12/14/202107:54DJNBristol Myers, Immatics to Collaborate on IMA401
12/14/202106:59BWImmatics and Bristol Myers Squibb Enter Into Global..
12/14/202101:56TRMNBristol Myers Squibb Rewards Shareholders; Shares Up 4.8%
12/13/202117:24SEEKBristol-Myers Squibb files for mixed shelf offering
12/13/202116:32EDGARAutomatic Shelf Registration Statement of Securities of..
12/13/202115:01DJNBristol-Myers Squibb on Track for Largest Percent Increase..
12/13/202107:45DJNBristol-Myers Squibb Raises Dividend, Buyback Authorization
12/13/202107:13SEEKBristol Myers Squibb raises dividend by 10% to $0.54,..
12/13/202106:59BWBristol Myers Squibb Announces Dividend Increase and..
12/11/202108:30BWBristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel)..
12/06/202118:28EDGARStatement of Changes in Beneficial Ownership (4)
12/06/202118:28EDGARStatement of Changes in Beneficial Ownership (4)
12/06/202118:28EDGARStatement of Changes in Beneficial Ownership (4)
12/04/202116:00SEEKBristol is one of the worst performing biopharmas this year...
12/03/202107:46DJNBristol Myers Squibb Gets FDA Acceptance of sBLA for..
12/03/202107:12SEEKFDA accepts for priority review Bristol Myers's Reblozyl..
12/03/202106:59BWU.S. Food and Drug Administration Accepts for Priority..
11/29/202108:02SEEKFDA and EMA accepts Bristol Myers' applications for..
11/29/202107:59DJNBristol-Myers Squibb: Deucravacitinib Applications Advance..
11/29/202106:59BWBristol Myers Squibb’s Applications for Deucravacitinib for..
11/24/202117:25EDGARStatement of Changes in Beneficial Ownership (4)
11/24/202101:20TRMNBristol Myers Squibb Gets EC Approval for Zeposia
11/23/202107:44DJNBristol Myers Gets Europe OK for Zeposia in Ulcerative..
11/23/202107:25SEEKBristol Myers' Zeposia OK'd in Europe for ulcerative colitis..
See more news about this stock »
Your Recent History
NYSE
BMY
Bristol My..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220128 00:30:11